GSK

Akorn Inc. Scores Two Generic Approvals from the FDA
Akorn Inc. Scores Two Generic Approvals from the FDA
BioSpace
Akorn
FDA
generics
Flonase
GSK
Lotemax
Bausch + Lomb
Flag link:
A pivotal test of an experimental malaria vaccine set to begin
A pivotal test of an experimental malaria vaccine set to begin
Stat
GSK
vaccines
malaria
Flag link:
GSK, AstraZeneca explore continuous manufacturing in partnership with CPI
GSK, AstraZeneca explore continuous manufacturing in partnership with CPI
Biopharma Dive
GSK
AstraZeneca
continuous manufacturing
drug manufacturing
Flag link:
GSK wins U.S. nod for two-drug HIV combination
GSK wins U.S. nod for two-drug HIV combination
Yahoo/Reuters
GSK
FDA
HIV
Dovato
Flag link:
The top 15 pharma companies by 2018 revenue
The top 15 pharma companies by 2018 revenue
Fierce Pharma
JNJ
Roche
Pfizer
Novartis
Merck
GSK
Sanofi
AbbVie
Bayer
Eli Lilly
Amgen
Bristol-Myers Squibb
Gilead Sciences
Teva Pharmaceutical
AstraZeneca
Flag link:
GSK adds to COPD pipeline as Exscientia deal bears fruit
GSK adds to COPD pipeline as Exscientia deal bears fruit
Pharmaforum
GSK
COPD
Exscientia
artificial intelligence
R&D
Flag link:
U.S., China key to GSK's consumer venture with Pfizer
U.S., China key to GSK's consumer venture with Pfizer
Yahoo/Reuters
China
GSK
Pfizer
consumer healthcare
Flag link:
Go or no go? Abbvie, Glaxo and Heron await FDA verdicts
Go or no go? Abbvie, Glaxo and Heron await FDA verdicts
EP Vantage
FDA
AbbVie
Heron Therapeutics
HTX-011
GSK
dolutegravir/lamivudine
risankizumab
Gimoti
Evoke Pharma
Flag link:
GSK mulls filings for multiple myeloma drug
GSK mulls filings for multiple myeloma drug
Pharmaforum
GSK
GSK2857916
antibody-drug conjugate
Multiple Myeloma
Flag link:
Will GSK/Tesaro’s Checkpoint Inhibitor Be Able to Compete With Merck’s Keytruda?
Will GSK/Tesaro’s Checkpoint Inhibitor Be Able to Compete With Merck’s Keytruda?
BioSpace
GSK
Tesaro
Merck
Keytruda
endometrial cancer
dostarlimab
Flag link:
Emma Walmsley earns £1M pay rise in her first full year at GSK's helm — but £5.9M package still trails other Big Pharma CEOs
Emma Walmsley earns £1M pay rise in her first full year at GSK's helm — but £5.9M package still trails other Big Pharma CEOs
Endpoints
GSK
Emma Walmsley
Pharma CEOs
executive pay
Flag link:
Mylan's Advair generic pressures GSK with strong launch
Mylan's Advair generic pressures GSK with strong launch
BioPharma Dive
GSK
Mylan
generics
Advair
Wixela Inhub
Flag link:
Top 10 drugs losing exclusivity in 2019
Top 10 drugs losing exclusivity in 2019
Fierce Pharma
market exclusivity
patents
Rituxan
Lyrica
Herceptin
Avastin
Epclusa
Harvoni
Pfizer
Roche
Gilead Sciences
Amgen
GSK
Allergan
Individor
Flag link:
Mylan launches Advair generic at 70% discount in US
Mylan launches Advair generic at 70% discount in US
Pharmaforum
Mylan
GSK
Advair
generics
Flag link:
Pharma companies clear the R&D decks in Q4
Pharma companies clear the R&D decks in Q4
Pharmaforum
R&D
GSK
Sanofi
Eli Lilly
Roche
Gilead Sciences
Flag link:
Artificial Intelligence Gaining Ground in Drug Development
Artificial Intelligence Gaining Ground in Drug Development
BioSpace
CASP
machine learning
artificial intelligence
drug development
Merck
Takeda
Atomwise
Bayer
GSK
Google DeepMind
Recursion Pharmaceuticals
Flag link:
Glaxo (GSK) Beats on Q4 Earnings, to Focus on Oncology in '19
Glaxo (GSK) Beats on Q4 Earnings, to Focus on Oncology in '19
Yahoo/Zacks.com
GSK
earnings
Flag link:
Amid R&D rejigs, GlaxoSmithKline axes 6 pipeline assets
Amid R&D rejigs, GlaxoSmithKline axes 6 pipeline assets
Fierce Biotech
GSK
R&D
Flag link:
Sales of shingles vaccine boost profits at GSK
Sales of shingles vaccine boost profits at GSK
Yahoo/Reuters
GSK
earnings
vaccines
shingles
Shingrix
Flag link:
Mylan’s Generic Advair Breathes New Life into Asthma Market
Mylan’s Generic Advair Breathes New Life into Asthma Market
Xtalks
Mylan
GSK
Advair
generics
FDA
asthma
Wixela Inhub
Flag link:

Pages